Across TCGA pan-cancer cohorts, MAPRE3-AS1 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of MAPRE3-AS1’s most consistent transcriptional readouts.
The strongest signal is observed in kidney chromophobe (KICH), where MAPRE3-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MAPRE3-AS1 is over-expressed in tumor, although a few such as KIRC and BRCA show the opposite, repressed pattern.
KICH, KIRC, and BRCA are the cancer types where MAPRE3-AS1 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MAPRE3-AS1 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.